{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T22:32:37Z","timestamp":1788474757947,"version":"build-2803163510"},"reference-count":25,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","diabetesresearchclinicalpractice.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Diabetes Research and Clinical Practice"],"published-print":{"date-parts":[[2023,8]]},"DOI":"10.1016\/j.diabres.2023.110816","type":"journal-article","created":{"date-parts":[[2023,7,5]],"date-time":"2023-07-05T02:23:37Z","timestamp":1688523817000},"page":"110816","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Insulin pump therapy in type 1 diabetes is associated with lower indices of Non-Alcoholic Fatty Liver in non-obese women but not men"],"prefix":"10.1016","volume":"202","author":[{"given":"Giuseppe Della","family":"Pepa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberta","family":"Lupoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Masulli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosalia","family":"Boccia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raffaele","family":"De Angelis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salvatore","family":"Gianfrancesco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmen","family":"Rainone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela Albarosa","family":"Rivellese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Annuzzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lutgarda","family":"Bozzetto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.diabres.2023.110816_b0005","doi-asserted-by":"crossref","unstructured":"Wang XJ, Malhi H. Nonalcoholic fatty liver disease. Ann Int Med 2018; 9: ITC65-ITC80. doi: 10.7326\/AITC201811060.","DOI":"10.7326\/AITC201811060"},{"key":"10.1016\/j.diabres.2023.110816_b0010","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1111\/dom.12973","article-title":"Non-alcoholic fatty liver disease (NAFLD) prevalence and its metabolic associations in patients with type 1 diabetes and type 2 diabetes","volume":"11","author":"Cusi","year":"2017","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.diabres.2023.110816_b0015","doi-asserted-by":"crossref","first-page":"3842","DOI":"10.1210\/clinem\/dgaa575","article-title":"Prevalence of Nonalcoholic Fatty Liver Disease (NAFLD) in Patients With Type 1 Diabetes Mellitus: A Systematic Review and Meta-Analysis","volume":"12","author":"de Vries","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.diabres.2023.110816_b0020","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.ijcard.2016.10.040","article-title":"Nonalcoholic fatty liver disease is independently associated with an increased incidence of cardiovascular disease in adult patients with type 1 diabetes","volume":"225","author":"Mantovani","year":"2016","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.diabres.2023.110816_b0025","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.2337\/dc13-2704","article-title":"Nonalcoholic fatty liver disease is independently associated with an increased incidence of chronic kidney disease in patients with type 1 diabetes","volume":"6","author":"Targher","year":"2014","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabres.2023.110816_b0030","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1111\/j.1365-2362.2010.02372.x","article-title":"Liver fat in obesity: role of type 2 diabetes mellitus and adipose tissue distribution","volume":"1","author":"Bozzetto","year":"2011","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.diabres.2023.110816_b0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabres.2021.108984","article-title":"Pioglitazone even at low dosage improves NAFLDD in type 2 diabetes: clinical and pathophysiological insights from a subgroup of the TOSCA.IT randomised trial","volume":"178","author":"Della Pepa","year":"2021","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/j.diabres.2023.110816_b0040","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.ejim.2022.03.025","article-title":"Non-alcoholic fatty liver disease: identical etiologic factors in patients with type 1 and type 2 diabetes","volume":"100","author":"de Vries","year":"2022","journal-title":"Eur J Intern Med"},{"key":"10.1016\/j.diabres.2023.110816_b0045","doi-asserted-by":"crossref","unstructured":"Mertens J, Van Gaal LF, Francque SM, De Block C. NAFLD in type 1 diabetes: overrated or underappreciated? Ther Adv Endocrinol Metab 2021; 12: 20420188211055557. doi: 10.1177\/20420188211055557.","DOI":"10.1177\/20420188211055557"},{"key":"10.1016\/j.diabres.2023.110816_b0050","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1016\/S2468-1253(21)00343-5","article-title":"Metabolic dysfunction-associated fatty liver disease and insulin resistance in type 1 diabetes","volume":"12","author":"Snaith","year":"2021","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.diabres.2023.110816_b0055","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1007\/s13679-022-00477-x","article-title":"Highlighting the Role of Obesity and Insulin Resistance in Type 1 Diabetes and Its Associated Cardiometabolic Complications","volume":"3","author":"Karamanakos","year":"2022","journal-title":"Curr Obes Rep"},{"key":"10.1016\/j.diabres.2023.110816_b0060","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1001\/jama.2017.13994","article-title":"Association of Insulin Pump Therapy vs Insulin Injection Therapy With Severe Hypoglycemia, Ketoacidosis, and Glycemic Control Among Children, Adolescents, and Young Adults With Type 1 Diabetes","volume":"14","author":"Karges","year":"2017","journal-title":"JAMA"},{"key":"10.1016\/j.diabres.2023.110816_b0065","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/1471-230X-6-33","article-title":"The Fatty Liver Index: a simple and accurate predictor of hepatic steatosis in the general population","volume":"6","author":"Bedogni","year":"2006","journal-title":"BMC Gastroenterol"},{"key":"10.1016\/j.diabres.2023.110816_b0070","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.dld.2009.08.002","article-title":"Hepatic steatosis index: a simple screening tool reflecting nonalcoholic fatty liver disease","volume":"7","author":"Lee","year":"2010","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.diabres.2023.110816_b0075","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1186\/1476-511X-10-183","article-title":"Cut-off points of the visceral adiposity index (VAI) identifying a visceral adipose dysfunction associated with cardiometabolic risk in a Caucasian Sicilian population","volume":"10","author":"Amato","year":"2011","journal-title":"Lipids Health Dis"},{"key":"10.1016\/j.diabres.2023.110816_b0080","doi-asserted-by":"crossref","first-page":"626","DOI":"10.2337\/diabetes.49.4.626","article-title":"Can clinical factors estimate insulin resistance in type 1 diabetes?","volume":"4","author":"Williams","year":"2000","journal-title":"Diabetes"},{"key":"10.1016\/j.diabres.2023.110816_b0085","doi-asserted-by":"crossref","first-page":"181","DOI":"10.2147\/DMSO.S189544","article-title":"The fatty liver index, a simple and useful predictor of metabolic syndrome: analysis of the Korea National Health and Nutrition Examination Survey 2010\u20132011","volume":"12","author":"Khang","year":"2019","journal-title":"Diabetes Metab Syndr Obes"},{"key":"10.1016\/j.diabres.2023.110816_b0090","doi-asserted-by":"crossref","unstructured":"Parente EB, Dahlstr\u00f6m EH, Harjutsalo V, Inkeri J, Mutter S, Forsblom C, et al. The Relationship Between Body Fat Distribution and Nonalcoholic Fatty Liver in Adults With Type 1 Diabetes. Diabetes Care 2021; 7: 1706-1713. doi: 10.2337\/dc20-3175.","DOI":"10.2337\/dc20-3175"},{"key":"10.1016\/j.diabres.2023.110816_b0095","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.2337\/db19-0324","article-title":"Iatrogenic Hyperinsulinemia, Not Hyperglycemia, Drives Insulin Resistance in Type 1 Diabetes as Revealed by Comparison With GCK-MODY (MODY2)","volume":"8","author":"Gregory","year":"2019","journal-title":"Diabetes"},{"key":"10.1016\/j.diabres.2023.110816_b0100","doi-asserted-by":"crossref","first-page":"215","DOI":"10.2337\/db09-0354","article-title":"Chronic peripheral hyperinsulinemia in type 1 diabetic patients after successfully combined pancreas-kidney transplantation does not affect ectopic lipid accumulation in skeletal muscle and liver","volume":"1","author":"Stadler","year":"2010","journal-title":"Diabetes"},{"key":"10.1016\/j.diabres.2023.110816_b0105","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabres.2022.109819","article-title":"Metabolic determinants of NAFLDD in adults with type 1 diabetes","volume":"186","author":"Serdarova","year":"2022","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/j.diabres.2023.110816_b0110","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1002\/1522-2594(200102)45:2<179::AID-MRM1023>3.0.CO;2-D","article-title":"Fast elevation of the intramyocellular lipid content in the presence of circulating free fatty acids and hyperinsulinemia: a dynamic 1H-MRS study","volume":"2","author":"Brechtel","year":"2001","journal-title":"Magn Reson Med"},{"key":"10.1016\/j.diabres.2023.110816_b0115","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1093\/humupd\/dmac011","article-title":"Prevalence of PCOS and related hyperandrogenic traits in premenopausal women with type 1 diabetes: a systematic review and meta-analysis","volume":"4","author":"Bayona","year":"2022","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.diabres.2023.110816_b0120","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1111\/jgh.13814","article-title":"Fatty liver index and hepatic steatosis index for prediction of non-alcoholic fatty liver disease in type 1 diabetes","volume":"1","author":"Svikl\u0101ne","year":"2018","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.diabres.2023.110816_b0125","doi-asserted-by":"crossref","first-page":"2142","DOI":"10.2337\/diabetes.49.12.2142","article-title":"Pharmacokinetics and pharmacodynamics of subcutaneous injection of long-acting human insulin analog glargine, NPH insulin, and ultralente human insulin and continuous subcutaneous infusion of insulin lispro","volume":"12","author":"Lepore","year":"2000","journal-title":"Diabetes"}],"container-title":["Diabetes Research and Clinical Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016882272300579X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016882272300579X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T19:29:16Z","timestamp":1759174156000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S016882272300579X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8]]},"references-count":25,"alternative-id":["S016882272300579X"],"URL":"https:\/\/doi.org\/10.1016\/j.diabres.2023.110816","relation":{},"ISSN":["0168-8227"],"issn-type":[{"value":"0168-8227","type":"print"}],"subject":[],"published":{"date-parts":[[2023,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Insulin pump therapy in type 1 diabetes is associated with lower indices of Non-Alcoholic Fatty Liver in non-obese women but not men","name":"articletitle","label":"Article Title"},{"value":"Diabetes Research and Clinical Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.diabres.2023.110816","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"110816"}}